Rare disease levels of evidence: Time for a new bar?

Authors

Vera Bril
Henry J Kaminski, George Washington University

Document Type

Journal Article

Publication Date

9-5-2017

Journal

Neurology

Volume

89

Issue

10

Inclusive Pages

988-989

DOI

10.1212/WNL.0000000000004343

Keywords

Fatty Acids, Monounsaturated; Humans; Myasthenia Gravis; Prospective Studies; Rare Diseases; Rituximab

APA Citation

Bril, V., & Kaminski, H. (2017). Rare disease levels of evidence: Time for a new bar?. Neurology, 89 (10). http://dx.doi.org/10.1212/WNL.0000000000004343

Peer Reviewed

1